本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Revolution Medicines, Inc.

46.55
+0.31000.67%
盘后46.41-0.1375-0.30%19:17 EDT
成交量:363.23万
成交额:1.68亿
市值:87.02亿
市盈率:-10.29
高:47.04
开:46.80
低:45.18
收:46.24
52周最高:62.40
52周最低:29.17
股本:1.87亿
流通股本:1.59亿
量比:1.58
换手率:2.29%
股息:- -
股息率:- -
每股收益(TTM):-4.5252
每股收益(LYR):-3.5776
净资产收益率:-46.61%
总资产收益率:-26.47%
市净率:4.66
市盈率(LYR):-13.01

数据加载中...

2021/03/02

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/01

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/01

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/01

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/02/01

重要事件披露

8-K - Current report
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report
2020/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/10

重要事件披露

8-K - Current report
2020/07/06

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/06

SEC问询函

CORRESP [Cover] - Correspondence